Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2007 1
2008 4
2009 6
2010 3
2011 5
2012 6
2013 2
2014 3
2015 5
2016 5
2017 3
2018 4
2019 3
2020 4
2021 1
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Cohen EEW, Soulières D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ; KEYNOTE-040 investigators. Cohen EEW, et al. Lancet. 2019 Jan 12;393(10167):156-167. doi: 10.1016/S0140-6736(18)31999-8. Epub 2018 Nov 30. Lancet. 2019. PMID: 30509740 Clinical Trial.
Diagnosis and Treatment of Nasopharyngeal Carcinoma in Children and Adolescents - Recommendations of the GPOH-NPC Study Group.
Kontny U, Franzen S, Behrends U, Bührlen M, Christiansen H, Delecluse H, Eble M, Feuchtinger T, Gademann G, Granzen B, Kratz CP, Lassay L, Leuschner I, Mottaghy FM, Schmitt C, Staatz G, Timmermann B, Vorwerk P, Wilop S, Wolff HA, Mertens R. Kontny U, et al. Among authors: wilop s. Klin Padiatr. 2016 Apr;228(3):105-12. doi: 10.1055/s-0041-111180. Epub 2016 May 2. Klin Padiatr. 2016. PMID: 27135270 Review. English.
Friday leukemia: myth or reality?
Wilop S, Galm O, Thompson L, Osieka R, Brummendorf TH, Jost E. Wilop S, et al. Blood. 2010 Jan 28;115(4):912. doi: 10.1182/blood-2009-11-255240. Blood. 2010. PMID: 20110434 Free article. No abstract available.
DNA methylation changes in multiple myeloma.
Galm O, Wilop S, Reichelt J, Jost E, Gehbauer G, Herman JG, Osieka R. Galm O, et al. Among authors: wilop s. Leukemia. 2004 Oct;18(10):1687-92. doi: 10.1038/sj.leu.2403434. Leukemia. 2004. PMID: 15318245
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma.
Metselaar J, Lammers T, Boquoi A, Fenk R, Testaquadra F, Schemionek M, Kiessling F, Isfort S, Wilop S, Crysandt M. Metselaar J, et al. Among authors: wilop s. Drug Deliv Transl Res. 2023 Apr;13(4):915-923. doi: 10.1007/s13346-022-01268-6. Epub 2023 Jan 2. Drug Deliv Transl Res. 2023. PMID: 36592287 Free PMC article. Clinical Trial.
Treatment adherence and effectiveness in patients treated with carfilzomib-based therapy combinations for relapsed/refractory multiple myeloma in Germany: interim results from the non-interventional CARO study.
Knauf W, Uhlig J, von der Heyde E, Losem C, Ammon A, Nusch A, Schlag R, Schulz H, Janssen J, Welslau M, Wilop S, Vannier C, Siebenbach HU, Serrer L, Schuch A, Woerner SM, Engelhardt M, Potthoff K. Knauf W, et al. Among authors: wilop s. Leuk Lymphoma. 2024 Dec 9:1-11. doi: 10.1080/10428194.2024.2436034. Online ahead of print. Leuk Lymphoma. 2024. PMID: 39654362 Free article.
Quantitative analyses of DAPK1 methylation in AML and MDS.
Claus R, Hackanson B, Poetsch AR, Zucknick M, Sonnet M, Blagitko-Dorfs N, Hiller J, Wilop S, Brümmendorf TH, Galm O, Platzbecker U, Byrd JC, Döhner K, Döhner H, Lübbert M, Plass C. Claus R, et al. Among authors: wilop s. Int J Cancer. 2012 Jul 15;131(2):E138-42. doi: 10.1002/ijc.26429. Epub 2011 Nov 28. Int J Cancer. 2012. PMID: 21918973 Free PMC article.
Activated fibronectin-secretory phenotype of mesenchymal stromal cells in pre-fibrotic myeloproliferative neoplasms.
Schneider RK, Ziegler S, Leisten I, Ferreira MS, Schumacher A, Rath B, Fahrenkamp D, Müller-Newen G, Crysandt M, Wilop S, Jost E, Koschmieder S, Knüchel R, Brümmendorf TH, Ziegler P. Schneider RK, et al. Among authors: wilop s. J Hematol Oncol. 2014 Dec 14;7:92. doi: 10.1186/s13045-014-0092-2. J Hematol Oncol. 2014. PMID: 25498831 Free PMC article.
49 results